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A small-for-dates male infant developed respiratory distress and increasing metabolic acidosis with rapid deep respirations and a rapid thready pulse which failed to respond to the usual measures. At 36 hours he was found to have a blood glucose of 800 mg/100 ml, with acetone in the urine and was diagnosed as having diabetes mellitus with dehydration. He was given two injections of 2 units of insulin which reduced the blood glucose to only 680 mg/100 ml, and an attempt at rehydration led to cardiac arrest and death at 40 hours. At necropsy there was patchy haemorrhagic consolidation of the lungs, dilatation of the heart, thymic exhaustion, severe fatty change of liver, and cerebral oedema. Complete absence of islets of Langerhans was noted in the pancreas, and there were no isolated a or fi cells, though some collections of lymphocytes were present. Argentophil cells in the gut were scanty.
This was the fourth child of healthy unrelated parents, whose first child, a boy born severely small-for-dates, died under similar circumstances at 48 hours but no histological examination of the pancreas was undertaken. It is suggested that both boys had the same underlying pathology and that this might be a previously undescribed recessively or X-linked inherited condition. To date only 2 children have been reported with hyperornithinaemia, hyperammonaemia, and homocitrullinuria. In the case we report there was, in addition, a deficiency of mitochondrial carbamyl phosphate synthetase I (CPS I), the enzyme involved in the first step of the Krebs-Henseleit urea cycle. The enzyme is believed to be localized largely in hepatic mritochondria. The patient, a 9-year-old severely retarded boy, had a history of vomiting, aversion to food, episodes of lethargy, EEG changes, and raised SGOT since early infancy. He has been followed since the age of 7 years when increased urinary excretion of omithine and lysine and increased blood ornithine and ammonia were discovered. Restricted protein intake resulted in slight improvement in growth, but height and weight remain below the 3rd centile. He has speech impairment, increased tendon reflexes, markedly delayed bone age, and a slightly enlarged and firm liver.
His blood ornithine (up to 550 pmol/l) and ammonia (up to 270 ,tgN/100 ml), and urinary excretion of homocitrulline (up to 284 zmol/g creatinine) are all markedly increased. There is total absence of CPS I (and CPS II) in leucocytes and a decrease to 20% of normal activity in the liver.
Electron microscopy of biopsied liver tissue showed that in the nonreticulated cells mitochondria were either strikingly enlarged and filled with crystalloid structures, or small with numerous abnormal cristae. Many mitochondria showed a peculiar periodicity at the level of the inner membrane. The morphology of the mitochondria was thought to correlate with the biochemical data. Many of the previous reports on causes of neonatal mortality have the following faults. They are retrospective studies, they mix primary and secondary causes of death, they do not breakdown causes of extrinsic perinatal hypoxia (EPH), and such important causes as intrauterine growth retardation and neonatal necrotizing enterocolitis are excluded. The list of primary causes of death used by the Perinatal Mortality Committee of Quebec Province, Canada, was modified to avoid the above criticisms. The methodology and results of 100 consecutive necropsies, excluding macerated stillbirths, are reported. Respiratory distress syndrome (RDS) 31%, congenital anomalies 28%, and EPH 17% were the three commonest causes of death. In the low birthweight infants (<2500 g) RDS was the most frequent cause (46%), and in full birthweight infants (>2500 g) congenital anomalies were the most frequent (57%). Maternal, placental, or labour and delivery problems were associated with about half the cases of EPH. In 2 cases the cause of death remained unexplained, though sudden infant death syndrome may be a possibility.
Postperinatal deaths and unexpected deaths in infancy: prospective study. J. L. Emery. The
Children's Hospital, Sheffield.
Home unexpected deaths now constitute the largest group of postperinatal deaths. The state of babies at the time of birth, who had later been unexpected deaths, has been compared with control children and a scoring system devised in order to select children at increased risk of unexpected death (Protestos et al., 1973) .
A prospective study using this criteria has been carried out in Sheffield which suggests that the method is functioning, and also identifies children having a doubled risk of requiring hospitalization (Carpenter and Emery, 1974) . The study will be continued for a further year before a final report is made.
Fatty change in brains of perinatal and unexpected deaths. D. R. Gadson and J. L. Emery. Children's Hospital, Sheffield.
Earlier work showed that the presence of fat-laden cells in the CSF of children with hydrocephalus is an indicator of severe brain damage . The findings of such cells in CSF of some unexpected cot deaths and perinatal deaths stimulated a survey of the brains of such children to ascertain the likely site oforigin. This was found to be in the region of the corpus callosum, the septum pelucidum, fomix, and related regions of the lateral ventricles. A survey carried out of 200 brains of children dying in the postperinatal period indicated that the fatty change is principally related to two groups of children-early perinatal deaths associated with severe hypoxia and a number of the unexplained, unexpected deaths in infancy. Evidence was presented which indicated that this fatty change is pathological and suggests that it is a reaction to hypoxia in actively myelinating brain tissue. 
